Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review
PLOS ONE · 14.02.2025 · 20 (2) · e0314644
DOI: 10.1371/journal.pone.0314644 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 14.02.2025. Verfasst von Julia Prinz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Glaucoma, Ginkgo biloba, Plant Extracts. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study aims to analyse the efficacy of GBE administration in patients with glaucoma and healthy volunteers.
Methods
This systematic review was performed according to the PRISMA 2020 guidelines. All clinical studies investigating the efficacy of GBE administration on the intraocular pressure (IOP), the corrected pattern standard deviation (CPSD) and the mean deviation of visual field testing, and heart rate were considered. The weighted mean difference (MD) effect measure, 95% confidence interval (CI), and t-test were used for continuous variables.
Results
Data from 8 studies, including 428 patients, were retrieved. The mean age of all patients was 51.1 ± 15.5 years. The median follow-up was 3.7 (IQR 9.4) months. The administration of GBE was not associated with an improvement in IOP (MD -1.5; 95%CI -7.1 to 9.6; P = 0.5), mean deviation (MD 0.7; 95%CI -9.4 to 8.2; P = 0.8), CPSD (MD -1.6; 95%CI -3.8 to 6.9; P = 0.5), or heart rate (MD -2.5; 95%CI -11.5 to 16.5; P = 0.4) from baseline to the last follow-up. There was no difference between GBE versus the control group in IOP (MD 1.1; 95%CI -5.7 to 3.5; P = 0.4), mean deviation (MD -0.4; 95%CI -9.1 to 9.9; P = 0.9), CPSD (MD 0.3; 95%CI -6.8 to 6.2; P = 0.9), and heart rate (MD -1.3; 95%CI -15.1 to 17.7; P = 0.8) at the last follow-up.
Conclusion
Currently, the evidence is not sufficient to conclude that GBE affects IOP, mean deviation, CPSD, or heart rate in glaucoma patients and healthy volunteers. These conclusions must be interpreted with caution given the limitations of the reviewed studies, particularly the follow-up time of the included studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital RWTH Aachen, Aachen, Germany.
- Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
- Department of Orthopedics and Trauma Surgery, Academic Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy.
- Department of Life Sciences, Health, and Health Professions, Link Campus University, Rome, Italy.
ORCID-Profile: Julia Prinz, Verena Prokosch, Filippo Migliorini
Zitieren
APA
Prinz, J., Prokosch, V., Wang, X., Feng, Y., Walter, P., Fuest, M., & Migliorini, F. (2025). Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review. PLOS ONE, 20(2), e0314644. https://doi.org/10.1371/journal.pone.0314644
Vancouver
Prinz J, Prokosch V, Wang X, Feng Y, Walter P, Fuest M, et al. Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review. PLOS ONE. 2025;20(2):e0314644. doi:10.1371/journal.pone.0314644
BibTeX
@article{Prinz2025,
author = {Prinz, Julia and Prokosch, Verena and Wang, Xiaosha and Feng, Yuan and Walter, Peter and Fuest, Matthias and Migliorini, Filippo},
title = {Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {2},
pages = {e0314644},
doi = {10.1371/journal.pone.0314644}
}
EUVIMED